OpenAI secures major Disney investment as monetization pressure rises, launches GPT-5.2 to defend lead in intensifying AI race

OpenAI has received fresh backing from Disney as the AI developer faces pressure to strengthen monetization and expand commercial partnerships. The investment arrives just as OpenAI rolls out GPT-5.2, a next-generation model aimed at reinforcing its competitive edge amid escalating rivalry across the generative AI market.

Continue reading

Qisda’s Alpha Networks, Hitron back to profit in 3Q25 after two-year slump, signaling market rebound

After two years of industry-wide inventory corrections, Taiwan’s networking sector is showing early signs of recovery, with Qisda Group subsidiaries Alpha Networks and Hitron Technologies both returning to profitability in the third quarter of 2025. Their improved results coincide with stabilizing operations and renewed product momentum, including Alpha’s upcoming 1.6T liquid-cooled switch.

Continue reading

Rapidus secures Canon, SoftBank backing for 2nm chip ambitions

Canon has reportedly entered final negotiations to invest in a state-backed chipmaker, while SoftBank prepares to increase its financial support, marking a significant step in Japan’s bid to revitalize its semiconductor industry. Kyodo News reported that the funding aims to support mass production of 2nm chips at the Chitose plant in Hokkaido by the second half of fiscal 2027 and establish a foundation for future 1.4nm manufacturing.

Continue reading

Linde LienHwa and CPC launch Taiwan’s first hydrogen refueling stations

Linde LienHwa, Taiwan’s largest industrial gas supplier, opened two hydrogen refueling stations with CPC Corporation as the government prepares new incentives to build out hydrogen infrastructure and support early pilot projects. The LLH Tree Valley Demonstration Hydrogen Refueling Station in Tainan and CPC’s Nanzih station in Kaohsiung are the first facilities of their kind to enter operation in Taiwan and are expected to anchor the country’s initial hydrogen mobility trials.

Continue reading